Christopher O. Audu
Rating: 5.0 of 5
( out of 36 reviews )

Christopher O. Audu, MD, PhD

Languages spoken: English

Clinical Locations

Primary Location

University of Utah Hospital

Vascular Surgery
50 N Medical Dr
Salt Lake City , UT 84132
801-585-7676
Get Directions

Primary Children's Hospital

Pediatric Vascular Surgery
100 N Mario Capecchi Drive
Salt Lake City , UT 84113
801-581-3495
Get Directions

  • Christopher Audu MD, PhD, is an integrated residency-trained, adult and pediatric surgeon-scientist specializing in vascular surgery, medicinal chemistry, biophysical chemistry, immunology, and drug development as it relates to vascular disease and pathophysiology.

    Dr. Audu’s Clinical and Surgical Specialties Include:

    • Cerebrovascular disease
    • Upper extremity arterial and venous disease
    • Aortic pathology
    • Visceral artery disease
    • Aortoiliac occlusive disease
    • Peripheral arterial disease
    • Popliteal aneurysms
    • Popliteal entrapment syndrome
    • Iliac artery endofibrosis
    • Arteriovenous dialysis access
    • Pediatric vascular surgery

    Dr. Audu received his medical and graduate degrees (Chemistry) from Dartmouth. He then completed a 1-year preliminary internship in General Surgery at Dartmouth, and then a 7-year Integrated Vascular Surgery Residency at the University of Michigan.

    Dr. Audu’s Research Interests Include:

    • Immunology
    • Medicinal Chemistry
    • Biophysics
    • Epigenetic enzymes

    When working with every patient, Dr. Audu’s primary goal is to help fix vascular-related ailments in a manner that meets the patient's goals and needs within the scope of his expertise and practice. He strives to provide this patient-centered care by listening to each concern, gathering appropriate clinical information, and then making appropriate recommendations for care in a compassionate, competent way.

    In his spare time, Dr. Audu enjoys reading, creative writing, cooking, spending quality family time, hiking, road biking, and soccer.

    Specialties

    Patient Rating

    Rating: 5.0 out of 5
    5.0 /5
    ( out of 36 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

    UNIVERSITY HOSPITAL
    Rating: 5 out of 5

    My relationship with Dr. Audu is one of the most important relationships in my life. He keeps me alive

    UNIVERSITY HOSPITAL
    Rating: 5 out of 5

    Can't say enough good things about Dr Audu. He is great!

    UNIVERSITY HOSPITAL
    Rating: 5 out of 5

    Chris made me comfortable the moment we meet. He demonstrated a confidence that eased my tension. Explained why I was having this discussion about a blockage in a previous procedure. I don't have any symptoms right now and my health on this issue ok but needs monitoring. Chris was cautious but was not concerned it was not an immediate threat. I have had the best care from my past doctors and Chris was at the front of the line

    UNIVERSITY HOSPITAL
    Rating: 5 out of 5

    Dr. Audu was so kind and friendly. He explained my situation thoroughly and options for moving forward. He listened to my concerns and addressed each one. I would recommend Dr. Audu to anyone needing vascular services.

    UNIVERSITY HOSPITAL
    Rating: 5 out of 5

    Very honest and straightforward. Listened to my concerns and gave his honest opinion on how to proceed from this moment forward. Much appreciated.

    UNIVERSITY HOSPITAL
    Rating: 5 out of 5

    I will recommend Dr Audu to everyone. He took the time to explain everything to me and most importantly, he listened to me. When I am nervous, I am rather chatty.

    UH HOSPITALS AND CLINICS
    Rating: 5 out of 5

    After my first virtual visit with Dr. Adu I'm confident he can help me.

    UNIVERSITY HOSPITAL
    Rating: 5 out of 5

    Very personable, patient, and caring. Felt safe and heard. Great surgeon.

    UNIVERSITY HOSPITAL
    Rating: 5 out of 5

    Dr Audu has to be one of the VERY, VERYBEST!!

  • Christopher Audu MD, PhD, is an integrated residency-trained, adult and pediatric surgeon-scientist specializing in vascular surgery, medicinal chemistry, biophysical chemistry, immunology, and drug development as it relates to vascular disease and pathophysiology.

    Dr. Audu’s Clinical and Surgical Specialties Include:

    • Cerebrovascular disease
    • Upper extremity arterial and venous disease
    • Aortic pathology
    • Visceral artery disease
    • Aortoiliac occlusive disease
    • Peripheral arterial disease
    • Popliteal aneurysms
    • Popliteal entrapment syndrome
    • Iliac artery endofibrosis
    • Arteriovenous dialysis access
    • Pediatric vascular surgery

    Dr. Audu received his medical and graduate degrees (Chemistry) from Dartmouth. He then completed a 1-year preliminary internship in General Surgery at Dartmouth, and then a 7-year Integrated Vascular Surgery Residency at the University of Michigan.

    Dr. Audu’s Research Interests Include:

    • Immunology
    • Medicinal Chemistry
    • Biophysics
    • Epigenetic enzymes

    When working with every patient, Dr. Audu’s primary goal is to help fix vascular-related ailments in a manner that meets the patient's goals and needs within the scope of his expertise and practice. He strives to provide this patient-centered care by listening to each concern, gathering appropriate clinical information, and then making appropriate recommendations for care in a compassionate, competent way.

    In his spare time, Dr. Audu enjoys reading, creative writing, cooking, spending quality family time, hiking, road biking, and soccer.

    Board Certification and Academic Information

    Academic Departments Medicinal Chemistry -Adjunct Assistant Professor
    Surgery -Assistant Professor
    Academic Divisions Vascular Surgery

    Education history

    Undergraduate Religious Education - Crossroads Bible College A.A.
    Undergraduate Major: Chemistry; Minor: Mathematics - Purdue University B.Sc.
    Professional Medical Medicine - Geisel School of Medicine at Dartmouth M.D.
    Doctoral Training Chemistry - Dartmouth College Ph.D.
    Residency General Surgery - Dartmouth Hitchcock Medical Center Preliminary Resident
    Residency Integrated Vascular Surgery - University of Michigan Resident

    Selected Publications

    Journal Article

    1. Santosa KB, Kayward L, Matusko N, Jagsi R, Audu CO, Kwakye G, Waljee JF, Sandhu (2023). Incivility, Work Withdrawal, and Organizational Commitment Among US Surgeons. Annals of surgery, 277(3), 416-422. (Read full publication)
    2. Sharma SB, Melvin WJ, Audu CO, Bame M, Rhoads N, Wu W, Kanthi Y, Knight JS, Adili R, Holinstat MA, Wakefield TW, Henke PK, Moore BB, Gallagher KA, Obi A (2023). The histone methyltransferase MLL1/KMT2A in monocytes drives coronavirus-associated coagulopathy and inflammation. Blood, 141(7), 725-742. (Read full publication)
    3. Audu CO, Melvin WJ, Joshi AD, Wolf SJ, Moon JY, Davis FM, Barrett EC, Mangum KD, Deng H, Xing X, Wasikowski R, Tsoi LC, Sharma SB, Bauer TM, Shadiow J, Corriere MA, Obi AT, Kunkel SL, Levi B, Moore BB, Gudjonsson JE, Smith AM, Gallagher K (2022). Macrophage-specific inhibition of the histone demethylase JMJD3 decreases STING and pathologic inflammation in diabetic wound repair. Cellular & molecular immunology, 19(11), 1251-1262. (Read full publication)
    4. Wolf SJ, Audu CO, Joshi A, denDekker A, Melvin WJ, Davis FM, Xing X, Wasikowski R, Tsoi LC, Kunkel SL, Gudjonsson JE, O'Riordan MX, Kahlenberg JM, Gallagher K (2022). IFN-¿ is critical for normal wound repair and is decreased in diabetic wounds. JCI insight, 7(9), (Read full publication)
    5. Deng H, Konopka CJ, Prabhu S, Sarkar S, Medina NG, Fayyaz M, Arogundade OH, Vidana Gamage HE, Shahoei SH, Nall D, Youn Y, Dobrucka IT, Audu CO, Joshi A, Melvin WJ, Gallagher KA, Selvin PR, Nelson ER, Dobrucki LW, Swanson KS, Smith A (2022). Dextran-Mimetic Quantum Dots for Multimodal Macrophage Imaging In Vivo, Ex Vivo, and In Situ. ACS nano, 16(2), 1999-2012. (Read full publication)
    6. Audu CO, Dardik (2021). Nutrition in the management of peripheral arterial disease: should we pay more attention to what our patients eat?. JVS-vascular science, 3, 15-16. (Read full publication)
    7. Melvin WJ, Audu CO, Davis FM, Sharma SB, Joshi A, DenDekker A, Wolf S, Barrett E, Mangum K, Zhou X, Bame M, Ruan A, Obi A, Kunkel SL, Moore BB, Gallagher K (2021). Coronavirus induces diabetic macrophage-mediated inflammation via SETDB2. Proceedings of the National Academy of Sciences of the United States of America, 118(38), (Read full publication)
    8. Davis FM, Tsoi LC, Melvin WJ, denDekker A, Wasikowski R, Joshi AD, Wolf S, Obi AT, Billi AC, Xing X, Audu C, Moore BB, Kunkel SL, Daugherty A, Lu HS, Gudjonsson JE, Gallagher K (2021). Inhibition of macrophage histone demethylase JMJD3 protects against abdominal aortic aneurysms. The Journal of experimental medicine, 218(6), (Read full publication)
    9. Kemp MT, Rivard SJ, Anderson S, Audu CO, Barrett M, Fry BT, Lane M, Vu JV, Young BAC, Englesbe M, Sandhu G, Coleman D (2021). Trainee Wellness and Safety in the Context of COVID-19: The Experience of One Institution. Academic medicine, 96(5), 655-660. (Read full publication)
    10. Davis FM, Tsoi LC, Wasikowski R, denDekker A, Joshi A, Wilke C, Deng H, Wolf S, Obi A, Huang S, Billi AC, Robinson S, Lipinski J, Melvin WJ, Audu CO, Weidinger S, Kunkel SL, Smith A, Gudjonsson JE, Moore BB, Gallagher K (2020). Epigenetic regulation of the PGE2 pathway modulates macrophage phenotype in normal and pathologic wound repair. JCI insight, 5(17), (Read full publication)
    11. Davis FM, denDekker A, Joshi AD, Wolf SJ, Audu C, Melvin WJ, Mangum K, Riordan MO, Kunkel SL, Gallagher K (2020). Palmitate-TLR4 signaling regulates the histone demethylase, JMJD3, in macrophages and impairs diabetic wound healing. European journal of immunology, 50(12), 1929-1940. (Read full publication)
    12. Davis FM, denDekker A, Kimball A, Joshi AD, El Azzouny M, Wolf SJ, Obi AT, Lipinski J, Gudjonsson JE, Xing X, Plazyo O, Audu C, Melvin WJ, Singer K, Henke PK, Moore BB, Burant C, Kunkel SL, Gallagher K (2020). Epigenetic Regulation of TLR4 in Diabetic Macrophages Modulates Immunometabolism and Wound Repair. Journal of immunology (Baltimore, Md., 204(9), 2503-2513. (Read full publication)
    13. Audu CO, Coleman D (2019). Prioritizing personal well-being during vascular surgery training. Seminars in vascular surgery, 32(1-2), 23-26. (Read full publication)
    14. Audu CO, Columbo JA, Sun SJ, Perri JL, Goodney PP, Stone DH, Nolan BW, Suckow B (2019). Variation in timing and type of groin wound complications highlights the need for uniform reporting standards. Journal of vascular surgery, 69(2), 532-543. (Read full publication)
    15. Audu CO, Boniakowski AE, Robinson S, Dasika NL, Wakefield T, Coleman D (2017). Internal iliac venous aneurysm associated with pelvic venous insufficiency. Journal of vascular surgery. Venous and lymphatic disorders, 5(2), 257-260. (Read full publication)
    16. Guo B, Audu CO, Cochran JC, Mierke DF, Pellegrini (2014). Protein engineering of the N-terminus of NEMO: structure stabilization and rescue of IKKß binding. Biochemistry, 53(43), 6776-85. (Read full publication)
    17. Audu CO, Plati JJ, Pellegrini M, Mierke D (2014). Engineering a soluble parathyroid hormone GPCR mimetic. Proteins, 82(7), 1370-5. (Read full publication)
    18. Audu CO, Cochran JC, Pellegrini M, Mierke D (2013). Recombinant production of TEV cleaved human parathyroid hormone. Journal of peptide science, 19(8), 504-10. (Read full publication)
    19. Audu CO, O'Hara B, Pellegrini M, Wang L, Atwood WJ, Mierke D (2012). Reining in polyoma virus associated nephropathy: design and characterization of a template mimicking BK viral coat protein cellular binding. Biochemistry, 51(41), 8092-9. (Read full publication)
    20. Scott WL, Alsina J, Audu CO, Babaev E, Cook L, Dage JL, Goodwin LA, Martynow JG, Matosiuk D, Royo M, Smith JG, Strong AT, Wickizer K, Woerly EM, Zhou Z, O'Donnell M (2009). Distributed Drug Discovery, Part 2: global rehearsal of alkylating agents for the synthesis of resin-bound unnatural amino acids and virtual D(3) catalog construction. Journal of combinatorial chemistry, 11(1), 14-33. (Read full publication)
    21. Scott WL, Audu CO, Dage JL, Goodwin LA, Martynow JG, Platt LK, Smith JG, Strong AT, Wickizer K, Woerly EM, O'Donnell M (2009). Distributed Drug Discovery, Part 3: using D(3) methodology to synthesize analogs of an anti-melanoma compound. Journal of combinatorial chemistry, 11(1), 34-43. (Read full publication)

    Review

    1. Audu CO, Gordon AE, Obi AT, Wakefield TW, Henke P (2020). Inflammatory biomarkers in deep venous thrombosis organization, resolution, and post-thrombotic syndrome. Journal of vascular surgery. Venous and lymphatic disorders, 8(2), 299-305. (Read full publication)
    2. Audu CO, Wakefield TW, Coleman D (2019). Pediatric deep venous thrombosis. Journal of vascular surgery. Venous and lymphatic disorders, 7(3), 452-462. (Read full publication)